The Pharmaceutical Manufacturing segment focuses on the research, development, and production of a diverse portfolio of pharmaceutical products, including chemical drugs, Chinese medicines, and biopharmaceutical drugs. This segment encompasses the entire lifecycle of drug development, from initial research and formulation to large-scale manufacturing and quality control. R&D activities include drug discovery, pre-clinical studies, clinical trials, and the development of innovative formulations and delivery systems. The segment utilizes advanced technologies such as chemical synthesis, fermentation, and bioprocessing to produce a wide range of therapeutic products. These products address various therapeutic areas, including cardiovascular, respiratory, oncology, and anti-infectives, impacting patient outcomes by providing access to essential medicines. The segment holds a strong market position in China and Hong Kong, with a focus on quality and innovation. Future opportunities include expanding the product pipeline, investing in advanced manufacturing technologies, and exploring strategic partnerships to enhance market reach and competitiveness. Regulatory compliance and adherence to Good Manufacturing Practices (GMP) are critical aspects of this segment.

The Pharmaceutical Distribution segment is responsible for the efficient and reliable distribution of pharmaceutical products to hospitals, distributors, and retail pharmacies across Mainland China and Hong Kong. This segment focuses on providing warehousing, logistics, and value-added supply chain solutions to ensure timely and secure delivery of medications. Key activities include managing a vast network of distribution centers, implementing advanced inventory management systems, and maintaining cold chain logistics for temperature-sensitive products. The segment utilizes technologies such as warehouse management systems (WMS), transportation management systems (TMS), and track-and-trace solutions to optimize operations and ensure product integrity. It serves as a critical link between manufacturers and healthcare providers, ensuring that patients have access to the medications they need. The segment's market positioning is enhanced by its extensive distribution network, strong relationships with healthcare providers, and commitment to regulatory compliance. Future growth opportunities include expanding distribution capabilities, investing in digital supply chain solutions, and exploring partnerships to enhance market coverage and efficiency. Regulatory compliance, including adherence to Good Distribution Practices (GDP), is a core focus.

The Pharmaceutical Retail segment operates a network of retail pharmacies under the CR Care and Teck Soon Hong brands, providing direct access to pharmaceutical products and healthcare services for consumers. This segment focuses on offering a wide range of over-the-counter (OTC) medications, prescription drugs, and healthcare products, along with professional pharmaceutical advice and patient counseling. Key activities include managing pharmacy operations, ensuring product availability, and providing customer service. The segment utilizes technologies such as point-of-sale (POS) systems, inventory management software, and electronic health record (EHR) integration to enhance efficiency and customer experience. It addresses patient needs by providing convenient access to medications and healthcare information. The segment's market positioning is strengthened by its established brand presence, convenient locations, and commitment to customer service. Future opportunities include expanding the retail network, enhancing online pharmacy services, and integrating telehealth solutions. Regulatory compliance, including adherence to pharmacy regulations and patient privacy laws, is a critical aspect of this segment.